December 2, 2014—According to the American Cancer Society, lung cancer is the leading cause of cancer death among men and women. Approximately 85% to 90% of lung cancers are non–small cell lung cancer (NSCLC). Although numerous treatments for NSCLC have recently emerged, the outcomes for patients with this disease are still poor.
Med-IQ, an award-winning, ACCME-accredited provider of continuing medical education (CME), has released an educational CME series that simulates a real-life clinical scenario focused on first-line treatment and maintenance therapy for patients with advanced NSCLC. Composed of two interactive “Webisodes,” this series provides oncologists with the education needed to select and implement personalized treatment regimens for their patients with advanced NSCLC.
Case Explorations in Advanced Non–Small Cell Lung Cancer: A Clinical Cliffhangers Series is designed to enhance the health of patients with NSCLC by illustrating strategies for incorporating updated clinical guidelines that address tumor characterization, biomarker analysis, and the use of maintenance therapy. Oncologists and oncology nurses who watch these two 45-minute interactive, Web-based modules will follow a patient through various diagnoses, follow-up care, and changes to the treatment regimen.
Webisode 1: Personalized Therapy in the First-Line Setting
Webisode 2: Maintenance Therapy—Who, When, and What?
“Throughout both Webisodes, participants can consider a variety of clinical decisions at different stages of the disease,” said Mark A. Socinski, MD, Professor of Medicine and Thoracic Surgery at the University of Pittsburgh in Pittsburgh, PA. “This activity will help oncology clinicians apply current evidence when managing their patients with NSCLC.”
Mark A. Socinski, MD
Professor of Medicine and Thoracic Surgery
Director, Lung Cancer Section, Division of Hematology/Oncology
Clinical Associate Director, Lung SPORE
Co-Director, UPMC Lung Cancer Center of Excellence
Co-Director, Lung and Thoracic Malignancies Program
University of Pittsburgh
Med-IQ, America’s most respected provider of continuing medical education (CME), inspires healthcare professionals through award-winning activities that deliver sophisticated outcomes-based educational designs with measurable results in professional competence and performance. Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the California Board of Registered Nursing (CBRN), and the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing medical education to physicians, nurses, and pharmacists, respectively.
As a leader in the CME industry, Med-IQ has delivered 32 performance improvement (PI) and quality improvement (QI) initiatives that make use of systems-based training such as Crew Resource Management (CRM) to improve team performance and patient outcomes. These initiatives have achieved improvement in healthcare professional performance, quality of care, and patient outcomes. Med-IQ’s work in this space has been published 27 times in peer-reviewed journals, and the company has been recognized by the Alliance for Continuing Education in the Health Professions for excellence in CE research (William Campbell Felch Award 2013, 2011), educational collaborations (2013), outstanding CME outcomes assessment (2012), and exceptional leadership (Leadership Award 2013, President’s Award 2012). To learn more about Med-IQ, visit www.Med-IQ.com, like us on Facebook, follow us on Twitter, and connect with us on LinkedIn.
For more information, contact:
Senior Audience Development Manager
866 858 7434
Inspiring Medical Education.